AUDENTES THERAPEUTICS, INC. AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENTInvestors’ Rights Agreement • November 6th, 2015 • Audentes Therapeutics, Inc. • Biological products, (no disgnostic substances) • California
This Amended and Restated Investors’ Rights Agreement (this “Agreement”) is made and entered into as of October 8, 2015 by and among Audentes Therapeutics, Inc., a Delaware corporation (the “Company”), and each of the investors listed on Schedule A hereto, each of which is referred to in this Agreement as an “Investor,” any subsequent investor that becomes a party to this Agreement in accordance with Section 7.14 hereof and any holder of a Lender Warrant that becomes a party to this Agreement in accordance with Section 7.14 hereof.
OFFICE LEASE BY AND BETWEEN a California limited partnership AS LANDLORD AND AUDENTES THERAPEUTICS, INC., a Delaware corporation AS TENANT PREMISES: San Francisco, CaliforniaOffice Lease • November 6th, 2015 • Audentes Therapeutics, Inc. • Biological products, (no disgnostic substances) • California
THIS OFFICE LEASE (this “Lease”) is made as of the 17th day of October, 2013, by and between 101 Montgomery Street Co., a California limited partnership (“Landlord”), and Audentes Therapeutics, Inc., a Delaware Corporation (“Tenant”).
SUBLEASESublease • November 6th, 2015 • Audentes Therapeutics, Inc. • Biological products, (no disgnostic substances) • California
This Lease dated May 22, 1997, for reference purposes only, is by and between JOHN C. NICKEL (“Lessor”) and ATHENA NEUROSCIENCES, INC., a Delaware corporation (“Lessee”).
OFFICE LEASEOffice Lease • November 6th, 2015 • Audentes Therapeutics, Inc. • Biological products, (no disgnostic substances) • California
Access Laws: The Americans With Disabilities Act of 1990 (including the Americans with Disabilities Act Accessibility Guidelines for Building and Facilities) and all other Governmental Requirements relating to the foregoing.
